NS Partners’s Amgen AMGN Stock Holding History

NS Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-23,799	Closed	-$4.93M	–	92
2018 Q3	$4.93M	Sell	23,799 -6,074	-20%	-$1.2M	0.47%	71
2018 Q2	$5.51M	Hold	29,873	–	–	0.57%	70
2018 Q1	$5.09M	Sell	29,873 -446	-1%	-$81.9K	0.54%	71
2017 Q4	$5.27M	Buy	30,319 +383	+1%	+$67.8K	0.58%	65
2017 Q3	$5.58M	Buy	29,936 +9,528	+47%	+$1.69M	0.67%	62
2017 Q2	$3.52M	Buy	20,408 +1,267	+7%	+$206K	0.46%	73
2017 Q1	$3.14M	Sell	19,141 -8,493	-31%	-$1.41M	0.45%	75
2016 Q4	$4.04M	Sell	27,634 -706	-2%	-$106K	0.63%	68
2016 Q3	$4.73M	Sell	28,340 -41	-0.1%	-$6.93K	0.77%	56
2016 Q2	$4.32M	Sell	28,381 -6,074	-18%	-$944K	0.74%	57
2016 Q1	$5.17M	Buy	34,455 +2,473	+8%	+$367K	0.93%	44
2015 Q4	$5.19M	Sell	31,982 -3,327	-9%	-$523K	0.93%	43
2015 Q3	$4.88M	Sell	35,309 -741	-2%	-$117K	0.86%	54
2015 Q2	$5.53M	Buy	+36,050	New	+$5.77M	0.88%	53

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NS Partners's AMGN Position: Q4 2018 in Review

NS Partners sold out of Amgen (AMGN) in Q4 2018, closing a stake of 23,799 shares — an estimated $4.93M sold.

NS Partners first reported a position in AMGN in Q2 2015 and held it in 14 quarters. The position peaked at $5.58M in Q3 2017. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

NS Partners reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
NS Partners sold 23,799 Amgen shares in Q4 2018, an estimated $4.93M.
NS Partners first reported a position in Amgen in Q2 2015 and held it in 14 quarters.
NS Partners's Amgen position peaked at $5.58M in Q3 2017.
1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on NS Partners's 13F filing for Q4 2018, filed 12 Feb 2019.